Build a testing approach that is ready for its intended use. Creative BioMart supports endotoxin method selection, development, interference assessment, analytical transfer and routine testing enquiries. Start with your current procedure and the decision you need to support, then explore the services relevant to the next stage of your project.
A useful endotoxin procedure connects sample preparation, assay performance and reporting to a defined purpose. Selecting an assay format is only one part of that work. A method used to compare research samples may need a different evidence plan from one intended to assess a product against an established specification.
Our project review considers what is already known, what has changed and which evidence is still needed. Development, verification, validation and transfer address related but distinct questions. The scope should follow the material and intended use rather than applying the same study package to every enquiry.
The overview below connects our method support services across common project stages. Start where your project needs support, with interference testing available throughout.
Figure 1. An illustrative pathway; the scope and sequence depend on method readiness and project needs.
The sequence below illustrates a common progression. Enter at the stage that fits your project; an established method may proceed to transfer or routine testing after an appropriate readiness review. Work can return to development when a formulation, preparation or analytical change introduces a new question.
Identify a candidate approach using the required result, matrix, reporting range and practical constraints. Early work can examine whether preparation and dilution conditions offer a useful starting point before a broader study is planned.
Useful when: the method is undecided, sample quantity is limited or a complex matrix makes feasibility uncertain.
Decision to support: which approach merits further work, and what remains unresolved?
Develop sample preparation, controls and reporting conditions, then define the relevant verification or validation work. The evidence plan should reflect whether an established compendial procedure is being implemented, modified or replaced by an alternative approach.
Useful when: a candidate method needs product-specific conditions or existing evidence does not cover the intended use.
Decision to support: are the procedure and its performance sufficiently understood for the proposed application?
Review a procedure moving between laboratories or a proposed analytical change. Define the comparison, receiving-setting readiness, sample coverage and prospective acceptance criteria so the study can address the change being made.
Useful when: testing moves to another setting, the reagent or readout changes, or two procedures need a justified comparison.
Decision to support: can the procedure be implemented as intended, or do the approaches support the required analytical relationship?
Discuss repeat testing using a defined method, represented product and agreed reporting requirements. Review sample identity, procedure readiness and quality arrangements before establishing a routine schedule or accepting release-related samples.
Useful when: an established procedure needs scheduled execution for specified samples or batches.
Decision to support: what does a valid analytical result show against the agreed criterion?
A failed positive sample control, unusual background and changing recovery after sample contact are different observations. A targeted investigation starts with the finding and the controls needed to distinguish plausible causes.
Where relevant, distinguish immediate assay interference from recovery changes after a defined contact or holding period. These questions may require different experiments.
| Your situation | Recommended starting discussion |
|---|---|
| No method has been selected | Selection and feasibility: define the required result, matrix and practical constraints. |
| A method works in an initial screen | Development and evidence planning: establish conditions and determine what further demonstration is relevant. |
| Controls fail or recovery is inconsistent | Interference testing: review the observation, unspiked response and control design before assigning a cause. |
| The laboratory or analytical procedure is changing | Transfer and comparability: identify the change and define what the study must establish. |
| An established procedure needs repeat execution | Routine QC review: confirm method readiness, sample coverage and reporting arrangements. |
The useful output depends on the question. A feasibility conclusion, an evaluated preparation, a comparative study and a routine test report serve different purposes. Agree on the study design, acceptance criteria and documentation during scoping.
On smaller screens, scroll horizontally to view all columns.
| Service | Output to discuss | Boundary to define |
|---|---|---|
| Selection and feasibility | Candidate approach, exploratory findings and next-step recommendation | What the screen can establish with the available material |
| Development and validation | Preparation conditions, study evidence and procedural information | Relevant verification or validation characteristics and acceptance criteria |
| Interference testing | Control-based findings and preparation options or limitations | Mechanisms actually investigated and conclusions supported |
| Transfer and comparability | Implementation or comparison findings against a defined plan | Laboratories, methods, sample coverage and permitted conclusions |
| Routine QC | Results with the agreed sample identity, units and validity information | Specification, documentation needs and quality responsibilities |
ICH Q14 and Q2(R2) provide complementary development and validation principles. BET-specific compendial requirements and the selected procedure remain central to the evidence plan. A qualitative threshold procedure and a quantitative assay should not automatically receive identical performance studies.
Provide the material identity, composition, concentration, intended use and requested units. Include the relevant specification or analytical target, available quantity, sample count and any preparation or handling constraints.
Our team reviews the starting information to propose a focused scope. Sample requirements, study execution, reporting and schedule are confirmed for the project.
No. Start with the stage that addresses the current gap. An established procedure may need a focused transfer review or routine testing arrangement, while an unresolved matrix may benefit from feasibility or interference work first.
No. Feasibility explores whether an approach is worth advancing under defined constraints. Validation evaluates relevant performance against an intended use and planned criteria. Promising exploratory results do not establish a validated routine procedure.
No. The appropriate work depends on implementation, modification and intended use. Verification and product-specific suitability may address relevant requirements; an alternative or substantially changed procedure may need broader evidence. The study scope should be justified.
It can provide a starting point, but the experimental question needs to be defined. Immediate spike compatibility and recovery after endotoxin has contacted the original formulation over time are different assessments. A passing immediate control does not settle every masking concern.
No. Transfer addresses implementation in a receiving setting. A comparison assesses the relationship between defined analytical approaches. A combined change may require both, with a design that explains which conclusions the data can support.
No. The preparation, selected reaction and readout still need to work for the material and intended purpose. Prior reagent validation information helps inform the plan but does not replace assessment of the actual sample conditions.
No. The service concerns analytical testing under confirmed arrangements. Final release remains with the authorized quality function and considers the broader product requirements. Formal release-use requests require review before sample acceptance.
Not by themselves. This service addresses analytical procedures and their results within a defined study. Overall product comparability, clinical equivalence and acceptance of a manufacturing change are broader questions that require additional evidence.
Share your current stage, sample information and the decision you need to support. Our team will discuss the relevant service and a practical scope for moving the project forward.
Explore All Endotoxin Testing Services →
References
